India to South Africa: Rivaroxaban Export Trade Route
India has recorded 51 verified shipments of Rivaroxaban exported to South Africa, representing a combined trade value of $1.4M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $28.2K USD. The leading Indian exporter is MILAN LABORATORIES (INDIA) PRIVATE LIMITED, which accounts for 53% of total export value with 28 shipments worth $768.2K USD. On the buying side, AUSTELL PHARMACEUTICALS (PTY) LTD. is the largest importer in South Africa with $446.4K USD in purchases. The top 3 suppliers — MILAN LABORATORIES (INDIA) PRIVATE LIMITED, CIPLA LIMITED, MACLEODS PHARMACEUTICALS LTD — together control 77% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to South Africa Rivaroxaban corridor is one of India's established pharmaceutical export routes, with 51 shipments documented worth a combined $1.4M USD. The route is dominated by MILAN LABORATORIES (INDIA) PRIVATE LIMITED, which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's rivaroxaban manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $28.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with rivaroxaban's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 29.9%, placing it at rank #14 among India's top rivaroxaban export destinations globally.
On the import side, key buyers of Indian rivaroxaban in South Africa include AUSTELL PHARMACEUTICALS (PTY) LTD., MEDPRO PHARMACEUTICA PTY LTD T/A CI, TO THE ORDER and 9 others. AUSTELL PHARMACEUTICALS (PTY) LTD. is the single largest importer with 8 shipments valued at $446.4K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#14
- Annual growth+29.9%
- Demand growth+25.0%
- Regulatory ease79/100
Top 10 Indian Rivaroxaban Exporters to South Africa
Showing top 10 of 10 Indian suppliers exporting Rivaroxaban to South Africa, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED Avg $27.4K per shipment | 28 | $768.2K | 53.5% |
| 2 | CIPLA LIMITED Avg $65.3K per shipment | 3 | $195.9K | 13.6% |
| 3 | MACLEODS PHARMACEUTICALS LTD Avg $48.4K per shipment | 3 | $145.2K | 10.1% |
| 4 | TORRENT PHARMACEUTICALS LTD Avg $50.2K per shipment | 2 | $100.3K | 7.0% |
| 5 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED Avg $28.4K per shipment | 3 | $85.3K | 5.9% |
| 6 | LUPIN LIMITED Avg $16.3K per shipment | 3 | $48.9K | 3.4% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED Avg $16.2K per shipment | 3 | $48.7K | 3.4% |
| 8 | MILAN LABORATORIES INDIA PRIVATE LIMITED Avg $10.1K per shipment | 4 | $40.4K | 2.8% |
| 9 | MYLAN LABORATORIES LIMITED Avg $3.0K per shipment | 1 | $3.0K | 0.2% |
| 10 | INFUGEN PHARMA PRIVATE LIMITED Avg $1.1K per shipment | 1 | $1.1K | 0.1% |
This table shows the top 10 of 10 Indian companies exporting rivaroxaban to South Africa, ranked by total trade value. The listed exporters are: MILAN LABORATORIES (INDIA) PRIVATE LIMITED, CIPLA LIMITED, MACLEODS PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LTD, MILAN LABORATORIES (INDIA) PRIVATE LIMITED , LUPIN LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, MILAN LABORATORIES INDIA PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, INFUGEN PHARMA PRIVATE LIMITED. MILAN LABORATORIES (INDIA) PRIVATE LIMITED is the dominant supplier with 28 shipments worth $768.2K USD, giving it a 53% market share. The top 3 suppliers together account for 77% of the total trade value on this route.
Top 10 Rivaroxaban Importers in South Africa
Showing top 10 of 12 known buyers in South Africa receiving Rivaroxaban shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rivaroxaban in South Africa include AUSTELL PHARMACEUTICALS (PTY) LTD., MEDPRO PHARMACEUTICA PTY LTD T/A CI, TO THE ORDER, MACLEODS PHARMACEUTICALS SA (PTY), TRINITY PHARMA PTY LTD, among 12 total buyers. The largest importer is AUSTELL PHARMACEUTICALS (PTY) LTD., accounting for $446.4K USD across 8 shipments — representing 31% of all rivaroxaban imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUSTELL PHARMACEUTICALS (PTY) LTD. | 8 | $446.4K | 31.1% |
| 2 | MEDPRO PHARMACEUTICA PTY LTD T/A CI | 3 | $195.9K | 13.6% |
| 3 | TO THE ORDER | 9 | $192.5K | 13.4% |
| 4 | MACLEODS PHARMACEUTICALS SA (PTY) | 3 | $145.2K | 10.1% |
| 5 | TRINITY PHARMA PTY LTD | 2 | $100.3K | 7.0% |
| 6 | AUSTELL PHARMACEUTICALS (PTY) LIMITED | 9 | $89.9K | 6.3% |
| 7 | TO THE ORDER | 3 | $85.3K | 5.9% |
| 8 | TO THE ORDER OF'' | 4 | $79.7K | 5.5% |
| 9 | UPD LEA GLEN, PHARMA DYNAMICS C/O | 3 | $48.9K | 3.4% |
| 10 | RANBAXY PHARMACEUTICALS | 3 | $48.7K | 3.4% |
Showing top 10 of 12 Rivaroxaban importers in South Africa on this route.
Top 10 Rivaroxaban Formulations Imported by South Africa
Showing top 10 of 45 product formulations shipped on the India to South Africa Rivaroxaban route, ranked by trade value
South Africa imports a wide range of rivaroxaban formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA.GOODS/HARMLESS MEDICINE:REZALTO 20MG[75812x3x10=2274360 TABS]RIVAROXABAN20MG — accounts for $226.7K USD across 1 shipments. There are 45 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA.GOODS/HARMLESS MEDICINE:REZALTO 20MG[75812x3x10=2274360 TABS]RIVAROXABAN20MG | 1 | $226.7K | 15.8% |
| 2 | XABRIVA 20 MG (RIVAROXABAN TABS ) 4X7'S (18684 PAC) | 1 | $109.6K | 7.6% |
| 3 | PHARMA.GOODS/HARMLESS MEDICINE:REZALTO 20MG[25568x3x10=767040 TABS]RIVAROXABAN 20MG | 1 | $76.4K | 5.3% |
| 4 | MEDPRALTO 10MG TABLETS 28'S(RivaroxabanTablets Ph. Eur 10 mg)(PS:1X28'SX7640 PACK=213920 NOS) | 1 | $71.6K | 5.0% |
| 5 | MEDPRALTO 15MG TABLETS 42'S(RivaroxabanTablets Ph. Eur 15 mg)(PS:1X42'SX5400 PACK=226800 NOS) | 1 | $69.2K | 4.8% |
| 6 | XABANAR 20TABLETS RIVAROXABAN TABLETS 20MG BATCH NO BPT3M002 003 MFG DT FEB 2025 EXP DT JAN 2028 | 1 | $68.9K | 4.8% |
| 7 | PHARMACEUTICAL GOODS/HARMLESS MEDICINES-REZALTO 20MG RIVAROXABAN 20MG (QTY: 24590X3X10T= 737700 T) | 1 | $68.8K | 4.8% |
| 8 | PHARMACEUTICAL GOODS/HARMLESS MEDICINES-REZALTO 20MG (RIVAROXABAN 20MG) (QTY- 20099 X 3 X 10T)NOS | 3 | $59.3K | 4.1% |
| 9 | MEDPRALTO 20MG TABLETS 28'S(RivaroxabanTablets Ph. Eur 20 mg)(PS:1X28'SX6440 PACK=180320 NOS) | 1 | $55.1K | 3.8% |
| 10 | PHARMA.GOODS/HARMLESS MEDICINE:REZALTO 10MG[15342x3x10=460260 TABS]RIVAROXABAN 10MG | 1 | $38.2K | 2.7% |
Showing top 10 of 45 Rivaroxaban formulations imported by South Africa on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 17 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's rivaroxaban exports to South Africa are driven primarily by a handful of large-scale manufacturers. MILAN LABORATORIES (INDIA) PRIVATE LIMITED with 28 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MILAN LABORATORIES (INDIA) PRIVATE LIMITED, CIPLA LIMITED, MACLEODS PHARMACEUTICALS LTD — together account for 77% of total trade value on this route. The average shipment value of $28.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as xabriva 20 mg (rivaroxaban tabs ) 4x7's (18684 pac) and pharma.goods/harmless medicine:rezalto 20mg[25568x3x10=767040 tabs]rivaroxaban 20mg, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AUSTELL PHARMACEUTICALS (PTY) LTD. is the largest importer with 8 shipments worth $446.4K USD — representing 31% of all rivaroxaban imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.4M
- Avg. Shipment
- $28.2K
- Suppliers
- 10
- Buyers
- 12
- Transit (Sea)
- ~16 days
- Annual Growth
- +29.9%
Related Analysis
Reverse Direction
South Africa → India — Rivaroxaban (Import)Other Rivaroxaban Routes
Unlock the Full India to South Africa Rivaroxaban Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 51 shipments on this route.
Frequently Asked Questions — India to South Africa Rivaroxaban Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rivaroxaban to South Africa?
The leading Indian exporters of Rivaroxaban to South Africa are MILAN LABORATORIES (INDIA) PRIVATE LIMITED, CIPLA LIMITED, MACLEODS PHARMACEUTICALS LTD. MILAN LABORATORIES (INDIA) PRIVATE LIMITED holds the largest market share at approximately 53% of total trade value on this route.
Q What is the total value of Rivaroxaban exports from India to South Africa?
India exports Rivaroxaban to South Africa worth approximately $1.4M USD across 51 recorded shipments. The average value per shipment is $28.2K USD.
Q Which ports does India use to ship Rivaroxaban to South Africa?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 17 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to South Africa for Rivaroxaban?
The average transit time for Rivaroxaban shipments from India to South Africa is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to South Africa Rivaroxaban trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.9% with demand growth tracking at 25.0%. The route is ranked #14 among India's top Rivaroxaban export destinations globally.
Q How many suppliers are active on the India to South Africa Rivaroxaban route?
There are currently 10 active Indian suppliers exporting Rivaroxaban to South Africa. The market is moderately concentrated with MILAN LABORATORIES (INDIA) PRIVATE LIMITED accounting for 53% of total shipment value.
Q Who are the main importers of Rivaroxaban from India in South Africa?
The leading importers of Indian Rivaroxaban in South Africa include AUSTELL PHARMACEUTICALS (PTY) LTD., MEDPRO PHARMACEUTICA PTY LTD T/A CI, TO THE ORDER, MACLEODS PHARMACEUTICALS SA (PTY), TRINITY PHARMA PTY LTD. AUSTELL PHARMACEUTICALS (PTY) LTD. is the largest buyer with 8 shipments worth $446.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to South Africa export trade corridor identified from Indian Customs (DGFT) records for Rivaroxaban.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 12 importers in South Africa matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 51 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
51 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists